Duke at ARVO 2019

Tuesday, April 23, 2019

We are looking forward to an exciting 2019 ARVO Annual Meeting "From Bench to Bedside and Back." Duke Faculty and trainees will participate in almost 90 sessions during the 5 day meeting being held in Vancouver, Canada.

See you soon for a time for innovative research, engaging discussion, and visiting with our colleagues and friends.

View List of Presentations 

W. Daniel Stamer, PhD President-Elect 

We are proud that W. Daniel Stamer, PhD will become the next president of ARVO. Stamer has been serving as an ARVO trustee representing the Physiology/Pharmacology (PH) Section for the past 3 years. 

Stamer is the Joseph A.C. Wadsworth Professor of Ophthalmology and Professor of Biomedical Engineering at Duke University School of Medicine. His laboratory studies the disease of glaucoma using molecular, cellular and organ-based model systems, and seeks to identify and validate novel drug targets in the human conventional outflow pathway, such that novel treatment of ocular hypertension and glaucoma can be developed.

Expect great things for ARVO under his leadership.

Meeting Planning Committee Members

Noteworthy Presentations 

Saturday, April 27

 
Catherine Bowes Rickman, PhD
Complement Dysregulation/ Age-Related Macular Degeneration
Victor Perez, MD
Corneal Transplantation and Beyond 
Education Course: Ocular Immunology: Fundamentals, Disease Entities and Future Therapeutic Opportunities
8 a.m. - 12 p.m.
(separate registration required)

Sunday, April 28

W. Daniel Stamer, PhD
The Importance of Targeting Trabecular Outflow for the Treatment of Glaucoma
China-ARVO Workshop

 

Scott Cousins, MD
Elamipretide, a Mitochondria-Targeted Drug, for the Treatment of Vision Loss in Dry AMD with Noncentral Geographic Atrophy: Results of the Phase 1 ReCLAIM Study
Paper Session: Emerging AMD Therapeutics 
3:00 p.m. - 4:45 p.m.
 

 


Monday, April 29

Vadim Arshavsky, PhD
How to Build a Photoreceptor Disc?
Mini Symposium: Frontiers in Membrane Dynamics and Cellular Communication: Impact on vision and disease mechanisms
8:15 a.m. - 10 a.m.

 
 
 
Eleonora Lad, MD, PhD
Classification of Intermediate Age-Related Macular Degeneration by Short-Term Risk for Atrophy on Spectral Domain Optical Coherence Tomography
Paper Session: AMD-Clinical Research
4:00 p.m. - 5:45 p.m.
 
 
 
Vasantha Rao, PhD
Ankyrin-B is required for lens fiber cell lateral membrane organization, hexagonal symmetry, tension and function
Paper Session: Lens Cell Biology
4:00 p.m. - 5:45 p.m.
 
 
W. Daniel Stamer, PhD
By Targeting Tie2/VE-PTP in Schlemm’s Canal, AKB-9778 Lowers Intraocular Pressure via Increasing Outflow Facility in Mice
Paper Session: Aqueous Humor Dynamics and IOP
4:00 p.m. - 5:45 p.m.

Tuesday, April 30

Anthony Kuo, MD
Cynthia Toth, MD
Joseph Izatt, PhD

Special Interest Group: OCT Guided and Robotically Enabled Ophthalmic Surgery panel
7:00 a.m. - 8:30 a.m.
 
Alessandro Iannaccone, MD, FARVO
Basal Cell Carcinoma-Associated Retinopathy and Optic Neuropathy (BARN): A Novel Paraneoplastic Entity
Paper Session: Non-Melanoma Tumors: Genetics and Therapeutics
8:45 a.m. - 10:30 a.m.
 
 
 

Goldis Malek, PhD

Cooperative Roles of NURR1 with RXR and LXR in Retinal Pigment Epithelial (RPE) Cells Varies as a Function of Age and Aged-related Macular Degeneration (AMD)
Paper Session: RPE Biology in Health and Diseases
2:45 p.m. - 4:30 p.m.

 

Glenn Jaffe, MD
Treatment of Non-infectious Uveitis that Affects the Posterior Segment with a Single Intravitreal Fluocinolone Acetonide Insert (FAi) – 3-year results
Paper Session: Uveitis Clinical Epidemiology and Therapeutics
2:45 p.m.. - 4:30 p.m.​

 

 


Wednesday, May 1

Victor Perez, MD
Immune Mediated Early Corneal Nerve Damage Ocular Graft-Versus-Host Disease
Paper Session: Corneal Neuropathy and Neovascularization
8:15 a.m. - 10:00 a.m.

 

 

Xi Chen, MD, PhD
Capturing Macular Neurovascular Development in Infants with Retinopathy of Prematurity
Paper Session: Retinopathy of Prematurity
10:45 a.m. - 11:00 a.m

 

Sina Farsiu, PhD
Special Interest Group: Advances and Challenges in Utilization of Artificial intelligence in Ophthalmology Research and Clinical Practice
12:15 p.m. - 1:45 p.m.
 
 

Thursday, May 2

Daniel Saban, PhD
Elucidatiing niche-associated function of retinal microglia at the single cell level
Symposium: The single cell revolution: Novel insights and applications for single cell RNA sequencing in eye research
8:00 a.m. - 12:00 p.m.